Event Schedule
Commemoration of the FDA-Approval of Cisplatin
Friday, August 3, 2018
Reception
Chemistry Building
|
5:00 - 7:00 p.m. |
Registration/Reception (hors d’oeuvres) and Poster Session |
| 5:30 p.m. | Welcome by Richard Schwartz, NatSci Associate Dean for Graduate Education, Room 138 Chemistry |
| 5:00 - 7:00 p.m. | Self-guided tours of Barney Rosenberg’s Lab, Room 233 Chemistry |
Saturday, August 4, 2018
Main Event
Kellogg Center
| 7:00 a.m. | Registration and Continental Breakfast |
| 8:45 a.m. | Introductions and Welcome - Provost June Pierce Youatt (MSU) |
| 9:00 a.m. |
James Hoeschele (Eastern Michigan University) Discovery of the Antitumor Activity of Cisplatin: Participants, Events and Impact |
| 9:30 a.m. |
Michael Cleare (Skysong Innovations) Serendipity, Persistence and Innovative Clinicians: Comments on the Research, Development and Approval of Carboplatin |
| 10:00 a.m. |
Hilary Calvert (University College London) Clinical Development of Carboplatin: Succeeding Slowly is Better than Failing Fast |
| 10:30 a.m. | Break |
| 10:45 a.m. |
Bernhard Lippert (Technische Universität Dortmund) Working with Barnett Rosenberg: A Personal Appreciation of my Postdoctoral Time at MSU and on an Exciting Project, the Platinum Pyrimidine Blue |
| 11:15 a.m. |
Matthew Hall (NIH) The Pre-History and Future of Platinum Anticancer Drugs |
| 11:45 a.m. - 1:30 p.m. | Lunch |
| 1:30 p.m. | Welcome - Dave Washburn (MSU Foundation) |
| 1:45 p.m. |
Franco Muggia (NYU) Platinums, BRCA Mutations, Impaired DNA Repair: Factors in the Cure of Women’s Cancer |
| 2:15 p.m. |
Sophia Lunt (MSU) Deciphering Metabolic Rewiring in Cancer |
| 2:45 p.m. |
Anna Moore (MSU) Precision Nanomedicine in Cancer Therapy |
| 3:15 p.m. |
Jetze Tepe (MSU) Therapeutic Applications of Small Molecule Proteasome Activation |
| 3:45 p.m. | Break |
| 4:00 p.m. |
Keynote - Stephen Lippard (MIT) Understanding and Improving Cisplatin |
| 5:00 p.m. | Wrap up |
| 6:00 p.m. | Cocktail Hour |
| 7:00 p.m. | Dinner |
| 7:45 p.m. |
Lawrence Einhorn (Indiana University) Platinum and Testicular Cancer: An Oncological Success Story |
| 8:15 p.m. | John Cleland (1st patient cured by cisplatin) |
| 8:30 p.m. | Conclusion |